A device for treating chronic obstructive pulmonary disease, cystic fibrosis and bronchiectasis has received approval for inclusion in the NHS drug tariff approval, meaning it can be prescribed by clinicians with immediate effect.
Nebusal (sterile 7 per cent hypertonic sodium chloride solution) increases the mobilisation of secretions in the lower respiratory tract for patients with persistent mucus by a process of osmosis.
Introducing Nursing Times Learning
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Click on the topics below to get started: